Technology Transfer Office of University of Colorado
Technology Transfer Office of University of Colorado

News and Events

TTO Twitter


TTO Blog


Join Mailing List

Technology Transfer Office of University of Colorado


News and Events > Events

Faculty Seminar: Drug Targets, Screens, and Early-stage Drugs – Commercialization and IP Strategy

Thursday, April 22, 2010, noon to 1:00pm
Lunch available at 11:45
ATLAS 229, CU-Boulder>
(Event Flyer)

This seminar hosted by TTO and the Colorado Institute for Molecular Biotechnology (CIMB) will offer strategies and perspectives on commercializing early-stage biomedical technologies, with a particular focus on intellectual property protection.

  • Focused on drug targets, drug screens/selection platforms, early-stage drugs, and other therapeutic platform technologies
  • What patent strategies are available for these technologies?
  • How can you maximize the commercial viability and value of these technologies?
  • Will also include information on resources available to CU researchers through the Colorado Initiative in Molecular Biotechnology (CIMB).


Tad H. Koch  is a Professor of Chemistry & Biochemistry. Professor Koch has assembled a collection of issued and pending patents for his invention of anthracycline-based, anti-tumor drug candidates.

Robert D. Traver is a patent attorney with Sheridan Ross P.C., and has experience in the general areas of chemistry, pharmaceuticals and biotechnology. Rob is the attorney prosecuting Professor Koch’s portfolio of patent applications. 



This event is free and open to CU faculty from all campuses. Lunch will be provided – please RSVP by via email or at 303-735-6645.


Technology Transfer Office